Frankenfish Deadline
By PAM BERNS
When
Lewis and Clark made their journey west, they marvelled at the upstream
surge of fish they saw: “There was great joy with the natives last
night in consequence of the arrival of the Salmon.” Little did Lewis and
Clark anticipate the reality today—we have only three percent of the
Pacific salmon and steelhead as we had in 1806 in the Columbia and Snake
River systems. According to the Sierra Club, back then, settlers were
in awe at the abundance of the salmon. They could barely travel by canoe
because of so many fish.
Pacific salmon is considered one of
the world’s most healthy fish to consume. That is why it is so worrisome
for many to imagine risking today’s three percent remaining salmon by
permitting the approval of a genetically engineered (GE) salmon that
could put the remaining salmon at risk.
The
genetically-engineered fish developed by AquaBounty Technologies, Inc,
combine genes from a sea eel and a Chinook salmon. The fish grow
approximately twice as fast as farm-raised or wild salmon. The
genetically-engineered salmon grow so fast because of elevated growth
hormone IGF-1, a suspected carcinogen that was also of great concern to
many Americans a few years ago when rBGH growth hormones were given in
injections to dairy cows to increase the volume of milk. The
genetically-engineered recombinant bovine growth hormone was rejected by
the European Union, Canada and organic farmers in the U.S. Only a small
fraction of farmers use the bovine hormone any more, some because rBGH
is suspected to affect breast, prostate and colon cancer growth.
On April 26 the Food and Drug Administration will most likely give
its blessing to AquaBounty—a company that has a facility on Prince
Edward Island in Canada and another facility in Panama—to sell its
genetically engineered salmon to consumers in the United States.
AquaBounty says that these locations are not conducive to reproduction
of wild-type salmon because of temperatures, dams and acid rain.
Tens of thousands of Americans have written letters to lawmakers
objecting to the genetically-engineered fish. Some fishermen would like
to avoid flooding the fish market with too many fish; but most of the
AquaBounty fish would be sterile. But according to Ocean Conservancy, if
only 60 genetically-engineered fish were released into a population of
wild salmon—and they bred with native salmon—they’d decimate the natural
Pacific salmon in forty generations.
Remember the Asian Carp?
Remember the arrival of the Asian Carp in Chicago? The big, invasive
fish easily escaped the ponds in which they were raised and swam from
fish farms in Arkansas, up the Mississippi, north to Chicago. Now the
carp are threatening the fishing industry in the Great Lakes. The carp
escaped when the ponds flooded. Do we honestly believe that some local
trouble-maker wouldn’t throw a few genetically-engineered salmon in the
Pacific or that these salmon might not escape their ponds and breed with
native salmon?
Why do we assume that AquaBounty fish
are going to be contained in fish ponds (as was intended by those who
raised Asian carp) and not threaten native Pacific Salmon? Approximately
one percent of the engineered salmon are capable of reproducing. That’s
not zero.
Many assume that if we label the fish “genetically engineered,”
consumers will have a choice between native Pacific Salmon and AquaBounty
salmon at the grocery store. Unfortunately, since 1992,
genetically-engineered (GE) foods are not required by the FDA to be
labeled. Consumers unwittingly buy unlabeled foods every day—corn and
soy among them. But if the FDA accepts these fish, this will be the
first genetically-engineered animal to be accepted in the marketplace.
Genetically-engineered salmon should be labeled as such, otherwise
consumers might avoid fish all together. So far, grocery chains such as
Whole Foods and Aldi have raised their voices in objection to the GE
fish.
One of the concerns many have with this GE fish is
that it might generate higher levels of fish allergies. Every year
approximately 200 Americans die of allergies to fish, including
anaphylaxis, sudden low blood pressure and severe skin reactions.
We have little data on the potential higher levels of food allergies
that could be aggravated by the GE fish. This is no small matter. “In
tests,” reports Michael Hansen of Consumers Union, “there was a 52
percent increase in allergic potency.”
Body Malformations in the First Generations
According to a paper published at Virginia Tech, the genes of the
Atlantic and Chinook salmon are very similar. However there are some
potential differences between the transgenic and the wild-type fish,
such as body malformations in the first generations of the
genetically-engineered salmon. The diploid (two copies of each
chromosome) of wild-type Pacific salmon differ from the genetically
engineered salmon that have triploid copies, making them sterile. The
idea is that GE fish are larger because they don’t have the stress of
reproduction that the wild fish do. However, Canadian scientists found
that GE salmon became very aggressive and would eat other types of fish
they would not normally eat under some conditions. This behavior would
be impossible to reverse if genetically-engineered salmon were let loose
in the environment.
The FDA considers the
genetically-engineered salmon to be an animal drug instead of a novel
food. Many Americans are concerned that the FDA is facing a conflict of
interest that defers to business interests.
Consumers
Union’s Hansen maintains that “To base a conclusion of no additional
risk on exactly six engineered fish, then those data themselves suggest a
possible problem, is not responsible science or responsible risk
assessment. FDA owes it to the thousands of Americans who are allergic
to finfish to demand more data on the allergenicity of these engineered
salmon from AquaBounty.”
According to Jeffrey Smith of
Natural Grocers, regarding insensitive tests that AquaBounty did on the
IGF-1 hormone, “Levels were detected in only a few fish. Of these, the
GE salmon was 40 percent higher. Again, insufficient data combined with
faulty reasoning allowed the FDA to conclude that IGF-1 from GE salmon
is not a problem.”
It is a problem.
Published: April 15, 2013
Issue: Spring 2013 Issue